Retirement Systems of Alabama Sells 780 Shares of CME Group Inc. (NASDAQ:CME)

Retirement Systems of Alabama reduced its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 78,021 shares of the financial services provider’s stock after selling 780 shares during the period. Retirement Systems of Alabama’s holdings in CME Group were worth $18,119,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Meyer Handelman Co. purchased a new position in shares of CME Group during the fourth quarter valued at approximately $6,144,000. Worldquant Millennium Advisors LLC lifted its stake in CME Group by 58.4% during the 3rd quarter. Worldquant Millennium Advisors LLC now owns 613,828 shares of the financial services provider’s stock valued at $135,441,000 after acquiring an additional 226,306 shares in the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after acquiring an additional 142,692 shares during the last quarter. Bank of Montreal Can grew its stake in shares of CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after acquiring an additional 303,169 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA raised its holdings in shares of CME Group by 18.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,826,501 shares of the financial services provider’s stock valued at $403,017,000 after purchasing an additional 283,171 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of CME stock opened at $244.41 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The stock has a market capitalization of $88.08 billion, a P/E ratio of 25.70, a PEG ratio of 5.37 and a beta of 0.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm’s 50 day moving average is $235.20 and its 200 day moving average is $223.49.

CME Group announced that its Board of Directors has initiated a share repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.05%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CME shares. Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Keefe, Bruyette & Woods reduced their price objective on CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research note on Monday, January 13th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus target price of $229.27.

Read Our Latest Stock Report on CME

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.